These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37506683)

  • 21. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
    Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
    Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neighborhood-level disadvantages increase risk for invasive pneumococcal disease.
    Minassian D; Shan L; Dong C; Charania AN; Orihuela CJ; He C
    Am J Med Sci; 2024 May; 367(5):304-309. PubMed ID: 38340982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
    Hernández S; Muñoz-Almagro C; Ciruela P; Soldevila N; Izquierdo C; Codina MG; Díaz A; Moraga-Llop F; García-García JJ; Domínguez Á
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of Macrolide-Resistance in
    Gonzales BE; Mercado EH; Pinedo-Bardales M; Hinostroza N; Campos F; Chaparro E; Del Águila O; Castillo ME; Saenz A; Reyes I; Ochoa TJ
    Front Cell Infect Microbiol; 2022; 12():866186. PubMed ID: 35615398
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain.
    Ciruela P; Soldevila N; García-Garcia JJ; González-Peris S; Díaz-Conradi A; Redin A; Viñado B; Izquierdo C; Muñoz-Almagro C; Domínguez A;
    Emerg Infect Dis; 2022 Nov; 28(11):2321-2325. PubMed ID: 36220135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
    Dirkx KKT; Mulder B; Post AS; Rutten MH; Swanink CMA; Wertheim HFL; Cremers AJH
    Int J Infect Dis; 2021 Oct; 111():196-203. PubMed ID: 34455081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.
    Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C;
    Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a need for pneumococcal vaccination programs for the homeless to prevent invasive pneumococcal disease?
    Tyrrell G; Lee C; Eurich D
    Expert Rev Vaccines; 2021 Sep; 20(9):1113-1121. PubMed ID: 34365882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in the incidence of invasive infections caused by encapsulated bacteria after the onset of the COVID-19 pandemic.
    Guzzi L; Sambade JM; Christin MD; Rodriguez Cairoli F; Rodriguez A; Vicario S; Hinojosa Del Carpio M; Molinos J; Dimitroff P
    Rev Argent Microbiol; 2024; 56(1):62-68. PubMed ID: 37517907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.
    McIntosh EDG; Feemster K; Rello J
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-7. PubMed ID: 34406914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009.
    Rudolph K; Bruce M; Bruden D; Zulz T; Wenger J; Reasonover A; Harker-Jones M; Hurlburt D; Hennessy T
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):271-6. PubMed ID: 23276772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring factors shaping antibiotic resistance patterns in
    Kovacevic A; Smith DRM; Rahbé E; Novelli S; Henriot P; Varon E; Cohen R; Levy C; Temime L; Opatowski L
    Elife; 2024 Mar; 13():. PubMed ID: 38451256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial.
    Singleton R; Wenger J; Klejka JA; Bulkow LR; Thompson A; Sarkozy D; Emini EA; Gruber WC; Scott DA
    Pediatr Infect Dis J; 2013 Mar; 32(3):257-63. PubMed ID: 23001026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal vaccination in people living with HIV.
    Thornhill J; Sivaramakrishnan A; Orkin C
    Vaccine; 2015 Jun; 33(28):3159-60. PubMed ID: 25128803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.
    Poehling KA; Talbot TR; Griffin MR; Craig AS; Whitney CG; Zell E; Lexau CA; Thomas AR; Harrison LH; Reingold AL; Hadler JL; Farley MM; Anderson BJ; Schaffner W
    JAMA; 2006 Apr; 295(14):1668-74. PubMed ID: 16609088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.
    Talbot TR; Poehling KA; Hartert TV; Arbogast PG; Halasa NB; Mitchel E; Schaffner W; Craig AS; Edwards KM; Griffin MR
    Clin Infect Dis; 2004 Sep; 39(5):641-8. PubMed ID: 15356776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children.
    Keck JW; Wenger JD; Bruden DL; Rudolph KM; Hurlburt DA; Hennessy TW; Bruce MG
    Vaccine; 2014 Nov; 32(48):6478-84. PubMed ID: 25269095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.
    Chowers M; Regev-Yochay G; Mor O; Cohen-Poradosu R; Riesenberg K; Zimhony O; Chemtob D; Stein M; Dagan R; Levy I
    Hum Vaccin Immunother; 2017 Jan; 13(1):216-219. PubMed ID: 27648488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
    Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R; Muller M; Powis J; Rau N; Walmsley S; Tyrrell G; Bitnun A; McGeer A;
    Clin Infect Dis; 2016 Jan; 62(2):139-47. PubMed ID: 26354970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.